Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mood Disorder, Psychotic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06863909
What this trial is testing

Study on the Effectiveness of Journaling as an add-on to Cognitive Behavioral Therapy

Who this might be right for
Affective DisordersRuminationChildhood Trauma+4 more
University Hospital Tuebingen 80
Not applicableStudy completedNCT00683709
What this trial is testing

Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder

Who this might be right for
Bipolar Affective DisorderSchizoaffective Disorder
St. Joseph's Healthcare Hamilton 48
Not applicableStudy completedNCT04005794
What this trial is testing

Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training

Who this might be right for
SchizophreniaSchizo Affective DisorderSocial Skills
Vanderbilt University 50
Post-approval studies (Phase 4)Ended earlyNCT03643159
What this trial is testing

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Who this might be right for
SchizophreniaBipolar 1 DisorderMajor Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 2
Not applicableStudy completedNCT05593276
What this trial is testing

The Preliminary Effects of Empower@Home

Who this might be right for
DepressionDepressive DisorderBehavioral Symptoms+2 more
University of Michigan 70
Not applicableStudy completedNCT03379597
What this trial is testing

A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Central South University 136
Testing effectiveness (Phase 2)Study completedNCT00001482
What this trial is testing

New Drugs in the Treatment of Mood Disorders

Who this might be right for
Anxiety DisorderMood DisorderPsychotic Disorder
National Institute of Mental Health (NIMH) 60
Testing effectiveness (Phase 2)Looking for participantsNCT06340789
What this trial is testing

Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate

Who this might be right for
Symptom, CognitiveSchizophreniaSchizo Affective Disorder
National Cheng-Kung University Hospital 90
Not applicableUnknownNCT04641780
What this trial is testing

"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"

Who this might be right for
SchizophreniaMajor Depressive Disorder
Otsuka Pharmaceutical, Inc., Philippines 300
Not applicableWithdrawnNCT00801567
What this trial is testing

Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation

Who this might be right for
Bipolar DisorderSchizophreniaHealthy Controls
Mclean Hospital
Not applicableStudy completedNCT01866098
What this trial is testing

Naltrexone for Antipsychotic-Induced Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Yale University 144
Early research (Phase 1)Study completedNCT00790777
What this trial is testing

The Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 72
Not applicableStudy completedNCT04526067
What this trial is testing

In-person vs. Remote Wellness Support

Who this might be right for
Depressive Disorder, MajorBipolar DisorderSchizo Affective Disorder+1 more
The University of Texas Health Science Center at San Antonio 56
Not applicableUnknownNCT06643871
What this trial is testing

Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis

Who this might be right for
Schizophrenia; PsychosisSchizo Affective DisorderFirst Episode Psychosis (FEP)
Centre Hospitalier St Anne 40
Not applicableStudy completedNCT01526395
What this trial is testing

Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital

Who this might be right for
Major Depressive DisorderBipolar DisorderSchizophrenia
Johns Hopkins University 99
Testing effectiveness (Phase 2)Ended earlyNCT03868839
What this trial is testing

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizo Affective DisorderTreatment-resistant Schizophrenia
Xiaoduo Fan 6
Not applicableStudy completedNCT00512070
What this trial is testing

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Seattle Institute for Biomedical and Clinical Research 40
Early research (Phase 1)Study completedNCT00817154
What this trial is testing

Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI)

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
Dartmouth-Hitchcock Medical Center 38
Testing effectiveness (Phase 2)WithdrawnNCT04054973
What this trial is testing

L-arginine Study for Persistent Symptoms of Schizophrenia

Who this might be right for
Schizo Affective DisorderSchizophrenia
University of Massachusetts, Worcester
Large-scale testing (Phase 3)Study completedNCT00102518
What this trial is testing

Aripiprazole Open-Label, Safety and Tolerability Study

Who this might be right for
SchizophreniaBipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 325
Next Page